Erectile function after repeat saturation prostate biopsy: Our experience in 100 patients

Introduction: Erectile dysfunction (ED) incidence following repeat saturation prostate biopsy (SPBx) was evaluated. Materials and methods: From January 2011 to June 2012 295 patients underwent repeat transperineal SPBx (median 28 cores) under sedation. The indications for biopsy were: abnormal DRE,...

Full description

Bibliographic Details
Main Authors: Pietro Pepe, Francesco Pietropaolo, Giuseppe Dibenedetto, Francesco Aragona
Format: Article
Language:English
Published: PAGEPress Publications 2013-09-01
Series:Archivio Italiano di Urologia e Andrologia
Subjects:
Online Access:http://www.pagepressjournals.org/index.php/aiua/article/view/1946
id doaj-eea0b0ca692b4fc5b63b650e641ebd04
record_format Article
spelling doaj-eea0b0ca692b4fc5b63b650e641ebd042020-11-25T02:50:01ZengPAGEPress PublicationsArchivio Italiano di Urologia e Andrologia1124-35622282-41972013-09-0185313013210.4081/aiua.2013.3.1301266Erectile function after repeat saturation prostate biopsy: Our experience in 100 patientsPietro Pepe0Francesco Pietropaolo1Giuseppe Dibenedetto2Francesco Aragona3Urology Unit, Cannizzaro Hospital, CataniaUrology Unit, Cannizzaro Hospital, CataniaUrology Unit, Cannizzaro Hospital, CataniaUrology Unit, Cannizzaro Hospital, CataniaIntroduction: Erectile dysfunction (ED) incidence following repeat saturation prostate biopsy (SPBx) was evaluated. Materials and methods: From January 2011 to June 2012 295 patients underwent repeat transperineal SPBx (median 28 cores) under sedation. The indications for biopsy were: abnormal DRE, PSA > 10 ng/mL or included between 4.1-10 with free/total PSA < 25%. All patients were prospectively evaluated with the 5-item version of the International Index of Erectile Function (IIEF-5) at baseline and 1, 3 and 6 months from SPBx. Results: 100/200 men with benign histology and normal sexual activity completed the study; median IIEF-5 score before and after SPBx was equal to 18.3 (baseline) vs 17.8 (1 month later) vs 18 (3 months later) vs 18.1 (6 months later) (p > 0.05); in detail, 1 month from biopsy 5 (5%) men referred a mild ED that disappeared at 3 and 6 months evaluation. Conclusions: Repeat transperineal SPBx under sedation did not significantly worsened erectile function; the minimal risk of temporary post-biopsy ED could be previously discussed (not emphasised) with potent patients.http://www.pagepressjournals.org/index.php/aiua/article/view/1946Erectile dysfunctionSaturation prostate biopsySexualityProstate biopsy
collection DOAJ
language English
format Article
sources DOAJ
author Pietro Pepe
Francesco Pietropaolo
Giuseppe Dibenedetto
Francesco Aragona
spellingShingle Pietro Pepe
Francesco Pietropaolo
Giuseppe Dibenedetto
Francesco Aragona
Erectile function after repeat saturation prostate biopsy: Our experience in 100 patients
Archivio Italiano di Urologia e Andrologia
Erectile dysfunction
Saturation prostate biopsy
Sexuality
Prostate biopsy
author_facet Pietro Pepe
Francesco Pietropaolo
Giuseppe Dibenedetto
Francesco Aragona
author_sort Pietro Pepe
title Erectile function after repeat saturation prostate biopsy: Our experience in 100 patients
title_short Erectile function after repeat saturation prostate biopsy: Our experience in 100 patients
title_full Erectile function after repeat saturation prostate biopsy: Our experience in 100 patients
title_fullStr Erectile function after repeat saturation prostate biopsy: Our experience in 100 patients
title_full_unstemmed Erectile function after repeat saturation prostate biopsy: Our experience in 100 patients
title_sort erectile function after repeat saturation prostate biopsy: our experience in 100 patients
publisher PAGEPress Publications
series Archivio Italiano di Urologia e Andrologia
issn 1124-3562
2282-4197
publishDate 2013-09-01
description Introduction: Erectile dysfunction (ED) incidence following repeat saturation prostate biopsy (SPBx) was evaluated. Materials and methods: From January 2011 to June 2012 295 patients underwent repeat transperineal SPBx (median 28 cores) under sedation. The indications for biopsy were: abnormal DRE, PSA > 10 ng/mL or included between 4.1-10 with free/total PSA < 25%. All patients were prospectively evaluated with the 5-item version of the International Index of Erectile Function (IIEF-5) at baseline and 1, 3 and 6 months from SPBx. Results: 100/200 men with benign histology and normal sexual activity completed the study; median IIEF-5 score before and after SPBx was equal to 18.3 (baseline) vs 17.8 (1 month later) vs 18 (3 months later) vs 18.1 (6 months later) (p > 0.05); in detail, 1 month from biopsy 5 (5%) men referred a mild ED that disappeared at 3 and 6 months evaluation. Conclusions: Repeat transperineal SPBx under sedation did not significantly worsened erectile function; the minimal risk of temporary post-biopsy ED could be previously discussed (not emphasised) with potent patients.
topic Erectile dysfunction
Saturation prostate biopsy
Sexuality
Prostate biopsy
url http://www.pagepressjournals.org/index.php/aiua/article/view/1946
work_keys_str_mv AT pietropepe erectilefunctionafterrepeatsaturationprostatebiopsyourexperiencein100patients
AT francescopietropaolo erectilefunctionafterrepeatsaturationprostatebiopsyourexperiencein100patients
AT giuseppedibenedetto erectilefunctionafterrepeatsaturationprostatebiopsyourexperiencein100patients
AT francescoaragona erectilefunctionafterrepeatsaturationprostatebiopsyourexperiencein100patients
_version_ 1724740629219508224